WXJ-202, a novel Ribociclib derivative, exerts antitumor effects against breast cancer through CDK4/6

Cyclin-dependent kinases 4 and 6 (CDK4/6) are key regulatory proteins in the cell division and proliferative cycle in humans. They are overactive in many malignant tumors, particularly in triple-negative breast cancer (TNBC). Inhibition of CDK4/6 targets can have anti-tumor effects. Here, we designe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Jing, Liu, Wenwen, Xu, Yuxin, Xu, Zhou, Lv, Mingxiao, Feng, Jing, Lv, Jinyu, He, Xingbei, Zhang, Zhen, Xie, Mengru, Jing, Aixin, Wang, Xiujun, Ma, Jinming, Liu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894725/
https://www.ncbi.nlm.nih.gov/pubmed/36744210
http://dx.doi.org/10.3389/fphar.2022.1072194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894725/
https://www.ncbi.nlm.nih.gov/pubmed/36744210
http://dx.doi.org/10.3389/fphar.2022.1072194

Ejemplares similares